Stockreport

Spruce Biosciences Touts MPS IIIB Data, Targets Q4 BLA Submission at Oppenheimer Conference [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF considerations for the company's lead program in Sanfilippo syndrome type B (MPS IIIB) during a fireside chat at Oppenheimer's 36th Annual Healthcare and Life Sciences C [Read more]